<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>9712324</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmid">36241961</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="pmc">9712324</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="publisher-id">731</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" pub-id-type="doi">10.1007/s11682-022-00731-9</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Social and clinical demographics of the sample</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab1"><label>Table 1</label><caption><p>Social and clinical demographics of the sample</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Patients (<italic>n</italic> = 17)</th><th align="left">Healthy controls (<italic>n</italic> = 19)</th><th align="left">Test statistic</th><th align="left"><italic>P</italic> Value</th></tr></thead><tbody><tr><td align="left">Age (Mean ± S.D.)</td><td align="left">30.41 ± 6.78</td><td align="left">31.16 ± 6.71</td><td align="left"><italic>t</italic> = .331</td><td align="left"><italic>p</italic> = .743</td></tr><tr><td align="left">Gender (Male/Female)</td><td align="left">12/5</td><td align="left">13/6</td><td align="left"><italic>χ</italic><sup><italic>2</italic></sup> = .932</td><td align="left"><italic>p</italic> = .628</td></tr><tr><td align="left"><p>GAF Symptom Severity (Mean ± S.D.)</p><p>GAF Level of Functioning (Mean ± S.D.)</p></td><td align="left"><p>73.13 ± 13.15</p><p>73.44 ± 13.50</p></td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Duration of Illness (Mean ± S.D.)</td><td align="left">6.23 ± 5.21</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Age of Onset (Mean ± S.D.)</td><td align="left">24.38 ± 5.96</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Course of Illness (Remitting/Episodic/Continuous)</td><td align="left">10/4/3</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Medicated/Non-Medicated</td><td align="left">14/3</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">CPZ Equivalents (Mean mg ± S.D.)</td><td align="left">364 ± 3.57</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left"><p>Type of Medication (Olanzapine/Clozapine/Risperidone/</p><p>Aripiprazole)</p></td><td align="left">4/3/4/3</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">SSPI (Mean ± S.D.)</td><td align="left">8.88 ± 6.95</td><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Social and clinical demographics of the sample</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Patients (n = 17)</th><th align="left">Healthy controls (n = 19)</th><th align="left">Test statistic</th><th align="left">P Value</th></tr></thead><tbody><tr><td align="left">Age (Mean ± S.D.)</td><td align="left">30.41 ± 6.78</td><td align="left">31.16 ± 6.71</td><td align="left">t = .331</td><td align="left">p = .743</td></tr><tr><td align="left">Gender (Male/Female)</td><td align="left">12/5</td><td align="left">13/6</td><td align="left">χ2 = .932</td><td align="left">p = .628</td></tr><tr><td align="left">GAF Symptom Severity (Mean ± S.D.)GAF Level of Functioning (Mean ± S.D.)</td><td align="left">73.13 ± 13.1573.44 ± 13.50</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Duration of Illness (Mean ± S.D.)</td><td align="left">6.23 ± 5.21</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Age of Onset (Mean ± S.D.)</td><td align="left">24.38 ± 5.96</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Course of Illness (Remitting/Episodic/Continuous)</td><td align="left">10/4/3</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Medicated/Non-Medicated</td><td align="left">14/3</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">CPZ Equivalents (Mean mg ± S.D.)</td><td align="left">364 ± 3.57</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">Type of Medication (Olanzapine/Clozapine/Risperidone/Aripiprazole)</td><td align="left">4/3/4/3</td><td align="left"/><td align="left"/><td align="left"/></tr><tr><td align="left">SSPI (Mean ± S.D.)</td><td align="left">8.88 ± 6.95</td><td align="left"/><td align="left"/><td align="left"/></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>Tab2</table-id><table-label>Table 2</table-label><table-caption>ROIs for functional connectivity analysis (MNI coordinates)</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab2"><label>Table 2</label><caption><p>ROIs for functional connectivity analysis (MNI coordinates)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Brain Area</th><th align="left">X Axis</th><th align="left">Y Axis</th><th align="left">Z Axis</th></tr></thead><tbody><tr><td align="left"><p>Right Anterior Insula (SN)</p><p>(Palaniyappan and Liddle <xref ref-type="bibr" rid="CR27">2014</xref>)</p></td><td align="left">33
</td><td align="left">21</td><td align="left">–3</td></tr><tr><td align="left"><p>Right Orbital Frontoinsula (SN)</p><p>(Seeley et al. <xref ref-type="bibr" rid="CR34">2007</xref>)</p></td><td align="left">38</td><td align="left">26</td><td align="left">–10</td></tr><tr><td align="left"><p>Posterior Cingulate (DMN)</p><p>Kuhn and Gallinat <xref ref-type="bibr" rid="CR16">2013</xref>)</p></td><td align="left">–1</td><td align="left">–29</td><td align="left">26</td></tr><tr><td align="left"><p>Right dorsolateral PFC (dlPFC) (ECN)</p><p>(Seeley et al. <xref ref-type="bibr" rid="CR34">2007</xref>)</p></td><td align="left">44</td><td align="left">36</td><td align="left">20</td></tr><tr><td align="left"><p>Left Lingual Gyrus</p><p>(Kuhn and Gallinat <xref ref-type="bibr" rid="CR16">2013</xref>)</p></td><td align="left">–11</td><td align="left">–57</td><td align="left">2</td></tr><tr><td align="left"><p>Right Lingual Gyrus</p><p>(Kuhn and Gallinat <xref ref-type="bibr" rid="CR16">2013</xref>)</p></td><td align="left">11</td><td align="left">–55</td><td align="left">2</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">ROIs for functional connectivity analysis (MNI coordinates)</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left">Brain Area</th><th align="left">X Axis</th><th align="left">Y Axis</th><th align="left">Z Axis</th></tr></thead><tbody><tr><td align="left">Right Anterior Insula (SN)(Palaniyappan and Liddle ???)</td><td align="left">33
</td><td align="left">21</td><td align="left">–3</td></tr><tr><td align="left">Right Orbital Frontoinsula (SN)(Seeley et al. ???)</td><td align="left">38</td><td align="left">26</td><td align="left">–10</td></tr><tr><td align="left">Posterior Cingulate (DMN)Kuhn and Gallinat ???)</td><td align="left">–1</td><td align="left">–29</td><td align="left">26</td></tr><tr><td align="left">Right dorsolateral PFC (dlPFC) (ECN)(Seeley et al. ???)</td><td align="left">44</td><td align="left">36</td><td align="left">20</td></tr><tr><td align="left">Left Lingual Gyrus(Kuhn and Gallinat ???)</td><td align="left">–11</td><td align="left">–57</td><td align="left">2</td></tr><tr><td align="left">Right Lingual Gyrus(Kuhn and Gallinat ???)</td><td align="left">11</td><td align="left">–55</td><td align="left">2</td></tr></tbody></table></div></transformed-table></extracted-table><extracted-table><table-id>Tab3</table-id><table-label>Table 3</table-label><table-caption>Functional connectivity analysis results</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="Tab3"><label>Table 3</label><caption><p>Functional connectivity analysis results</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Patients-healthy controls</th><th align="left">Seed MNI coordinates</th><th align="left">Connecting cluster peak Voxel MNI coordinates</th><th align="left"><italic>P</italic> Value, peak intensity, cluster size</th></tr></thead><tbody><tr><td align="left">Left Lingual Gyrus-Middle Frontal Gyrus</td><td align="left">-11 -57 2</td><td align="left">-33 54 -6</td><td align="left">p(FDR) &lt; 0.001, T = 5.84, k = 286</td></tr><tr><td align="left">Left Lingual Gyrus-Middle Frontal Gyrus</td><td align="left">-11 -57 2</td><td align="left">-27 42 9</td><td align="left">Local maximum</td></tr><tr><td align="left">Left Lingual Gyrus-Middle Frontal Gyrus</td><td align="left">-11 -57 2</td><td align="left">-36 42 -12</td><td align="left">Local maximum</td></tr><tr><td align="left">Left Lingual Gyrus-Cingulate Gyrus</td><td align="left">-11 -57 2</td><td align="left">6 -15 30</td><td align="left">p(FDR) = 0.042, T = 4.75, k = 79</td></tr></tbody></table></table-wrap></original-table><transformed-table>Table 3<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Functional connectivity analysis results</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left">Patients-healthy controls</th><th align="left">Seed MNI coordinates</th><th align="left">Connecting cluster peak Voxel MNI coordinates</th><th align="left">P Value, peak intensity, cluster size</th></tr></thead><tbody><tr><td align="left">Left Lingual Gyrus-Middle Frontal Gyrus</td><td align="left">-11 -57 2</td><td align="left">-33 54 -6</td><td align="left">p(FDR) &lt; 0.001, T = 5.84, k = 286</td></tr><tr><td align="left">Left Lingual Gyrus-Middle Frontal Gyrus</td><td align="left">-11 -57 2</td><td align="left">-27 42 9</td><td align="left">Local maximum</td></tr><tr><td align="left">Left Lingual Gyrus-Middle Frontal Gyrus</td><td align="left">-11 -57 2</td><td align="left">-36 42 -12</td><td align="left">Local maximum</td></tr><tr><td align="left">Left Lingual Gyrus-Cingulate Gyrus</td><td align="left">-11 -57 2</td><td align="left">6 -15 30</td><td align="left">p(FDR) = 0.042, T = 4.75, k = 79</td></tr></tbody></table></div></transformed-table></extracted-table></extracted-tables-set>